We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
+12.59%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$18.9B
AUM Growth
+$3.55B
(+23%)
Cap. Flow
+$2.11B
Cap. Flow
% of AUM
11.15%
Top 10 Holdings %
Top 10 Hldgs %
14.56%
Holding
1,090
New
199
Increased
468
Reduced
192
Closed
179
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$216M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
+$129M |
| 3 |
Brown & Brown
BRO
|
+$121M |
| 4 |
Arthur J. Gallagher & Co
AJG
|
+$116M |
| 5 |
AKRO
Akero Therapeutics
AKRO
|
+$90.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$144M |
| 2 |
MetLife
MET
|
+$97.2M |
| 3 |
Travelers Companies
TRV
|
+$91.9M |
| 4 |
Electronic Arts
EA
|
+$91.9M |
| 5 |
SWTX
SpringWorks Therapeutics
SWTX
|
+$76M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.08% |
| 2 | Technology | 23.91% |
| 3 | Financials | 10.59% |
| 4 | Consumer Discretionary | 9.42% |
| 5 | Industrials | 7.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
CG Oncology
CGON
$6.1B
| $16.4M | 0.09% |
629,357
-135,000
| -18% | -$3.25M |
|
327
CAVA Group
CAVA
$7.51B
| $16.3M | 0.09% |
194,046
-46,900
| -19% | -$4M |
|
328
Roper Technologies
ROP
$38.8B
| $16.3M | 0.09% |
28,727
+11,828
| +70% | +$6.68M |
|
329
iShares MSCI China ETF
MCHI
$6.31B
| $16.3M | 0.09% |
295,508
+258,266
| +693% | +$13.7M |
|
330
Encompass Health
EHC
$11.2B
| $16.3M | 0.09% |
+132,604
| New | +$15.1M |
|
331
PayPal
PYPL
$49.5B
| $16.2M | 0.09% |
217,394
+178,052
| +453% | +$12.2M |
|
332
Alkermes
ALKS
$8.31B
| $16M | 0.08% |
558,465
-185,535
| -25% | -$5.52M |
|
|
SKX
333
DELISTED
Skechers
SKX
| $16M | 0.08% |
+253,000
| New | +$14.5M |
|
334
Armstrong World Industries
AWI
$7.58B
| $16M | 0.08% |
+98,224
| New | +$14.6M |
|
335
Chefs' Warehouse
CHEF
$4.54B
| $15.9M | 0.08% |
+249,758
| New | +$14.8M |
|
|
ACLX
336
DELISTED
Arcellx
ACLX
| $15.9M | 0.08% |
241,389
+76,084
| +46% | +$4.74M |
|
|
VTLE
337
DELISTED
Vital Energy
VTLE
| $15.8M | 0.08% |
979,536
-201,630
| -17% | -$3.3M |
|
338
GE Vernova
GEV
$268B
| $15.6M | 0.08% |
29,523
+6,213
| +27% | +$2.59M |
|
339
Applied Industrial Technologies
AIT
$13B
| $15.5M | 0.08% |
+66,711
| New | +$15.2M |
|
340
RLI Corp
RLI
$5.62B
| $15.5M | 0.08% |
214,375
+17,364
| +9% | +$1.3M |
|
341
NextEra Energy
NEE
$181B
| $15.5M | 0.08% |
222,679
+48,944
| +28% | +$3.4M |
|
342
Immunome
IMNM
$2.61B
| $15.4M | 0.08% |
1,658,663
+934
| +0.1% | +$7.66K |
|
|
GMS
343
DELISTED
GMS Inc
GMS
| $15.3M | 0.08% |
+140,513
| New | +$10.9M |
|
344
Dutch Bros
BROS
$8.91B
| $15.3M | 0.08% |
223,114
+14,087
| +7% | +$919K |
|
345
Texas Roadhouse
TXRH
$13.8B
| $15.2M | 0.08% |
81,328
| – | – |
|
346
ON Semiconductor
ON
$31.3B
| $15.2M | 0.08% |
290,756
+57,172
| +24% | +$2.49M |
|
347
Olin
OLN
$2.12B
| $15M | 0.08% |
+748,997
| New | +$15.6M |
|
348
Abbott
ABT
$185B
| $15M | 0.08% |
110,325
+233
| +0.2% | +$30.7K |
|
349
Olema Pharmaceuticals
OLMA
$985M
| $14.9M | 0.08% |
3,505,893
+2,027,986
| +137% | +$9.04M |
|
350
TJX Companies
TJX
$174B
| $14.9M | 0.08% |
120,769
+25,794
| +27% | +$3.27M |
|
Similar funds
PAM
TCIIS
UIM
Woodline Partners's Q2 2025 Portfolio in Review
As of Q2 2025, Woodline Partners held 1,090 positions worth $18.9B, up 23% from $15.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Woodline Partners deployed $2.11B of net new capital in Q2 2025, opening 199 new positions and adding to 468 existing holdings. Its largest new stake was Brown & Brown: 1,079,076 shares worth $120M.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 30% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was SpringWorks Therapeutics, an estimated $76M trimmed.
- Woodline Partners's largest Q2 2025 buy was Brown & Brown: 1,079,076 shares worth $120M.
- Woodline Partners added most to Microsoft in Q2 2025, an estimated $216M increase.
- Woodline Partners's biggest Q2 2025 reduction was SpringWorks Therapeutics, cutting an estimated $76M.
- Woodline Partners fully exited Lam Research in Q2 2025, selling an estimated $144M.
- Woodline Partners's ten largest holdings make up 15% of its $18.9B portfolio in Q2 2025.
- Woodline Partners opened 199 new positions and closed 179 in Q2 2025.
- Woodline Partners's portfolio value rose 23% quarter-over-quarter to $18.9B.
Based on Woodline Partners's 13F filing for Q2 2025, filed 14 Aug 2025.